Moderna
MRNA
#1289
Rank
โ‚น1.174 T
Marketcap
โ‚น3,053
Share price
-2.09%
Change (1 day)
-53.59%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -โ‚น358.47 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น4.98 Billion. In 2023 the company made an earning of -โ‚น329.57 Billion a decrease over its 2022 earnings that were of โ‚น810.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น358.47 Billion8.77%
2023 -โ‚น329.57 Billion-140.65%
2022 โ‚น810.74 B-27.81%
2021 โ‚น1.122 T-1911.15%
2020 -โ‚น62.01 Billion44.7%
2019 -โ‚น42.85 Billion28.63%
2018 -โ‚น33.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น2.96 Billion-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.392 T-483.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น3.53 Billion-99.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น15.78 Billion-95.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.074 T-395.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-โ‚น44.38 Billion-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.552 T-527.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น9.94 Billion-97.27%๐Ÿ‡บ๐Ÿ‡ธ USA